Roger L. Nation

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 869 citations · Full text

Polymyxin Antibiotics Colistin, Susceptibility Testing, Pharmacotherapy +19

Colistin Resistance in <i>Acinetobacter baumannii</i> Is Mediated by Complete Loss of Lipopolysaccharide Production

Jennifer H. Moffatt, Marina Harper, Paul F. Harrison et al. · Antimicrobial Agents and Chemotherapy · 2010 · 771 citations

Bacteriology, Antibiotic Resistance, Lipopolysaccharide Production +19

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

Samira M. Garonzik, Jian Li, Visanu Thamlikitkul et al. · Antimicrobial Agents and Chemotherapy · 2011 · 679 citations · Full text

Heteroresistance to Colistin in Multidrug-Resistant <i>Acinetobacter baumannii</i>

Jian Li, Craig R. Rayner, Roger L. Nation et al. · Antimicrobial Agents and Chemotherapy · 2006 · 536 citations · Full text

Bacterial Resistance, Antimicrobial Resistance Gene, Antimicrobial Susceptibility +14

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 417 citations